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Summary.-In a series of patients drawn from the Birmingham Regional Cancer
Registry (England) with tumours ofthe salivary glands, a significant excess of second
primary tumours was observed. For females, the excess was found mainly in
breast and bronchus and, for males, in prostate and skin. In a parallel series of
female breast-cancer patients, the observed number of second primary tumours in
salivary glands significantly exceeded expectation. These results supportthereported
association between salivary gland and breast cancer, and suggest that other
hormone-dependent sites are also at risk.
BERG focused interest on salivary gland
as a first primary site when he reported
that it showed a unique association with
breast as the second primary site. His
series was drawn from the Memorial
Hospital, New York (Berg, Hutter and
Foote, 1968). A similar survey of patients
from the Mayo Clinic (Moertel and Elve-
back, 1969) showed no evidence of the
association. In a third series, reported by
the Californian State Registry (Dunn et al.,
1972), an excess of breast tumours was
observed, but the difference from expecta-
tion was not significant.
The present survey, which forms part
of an investigation into multiple primary
cancer at the Birmingham Regional Cancer
Registry, was undertaken to test Berg's
hypothesis of an association between the
two sites. It is based on data collected at
the Registry over a period of 15 years for
825 patients registered for a tumour in a
major salivary gland or in ectopic tissue of
salivary-gland origin.
MATERIALS AND METHOD
Starting with the supposition that, for the
series of patients under observation with a
first primary, the risk of developing a second
primary tumour is the same as that for the
general population of incurring a first
primary, then, if the morbidity rates for the
general population are known, they can be
used as a basis for computing the number of
further tumours that would be expected to
occur in the series. Any deviation from
expectation can then be tested by means of a
suitable statistical test of significance.
As Moertel has pointed out, one ofthe basic
problems in multiple primary studies is that
of making a valid estimate of the expected
tumour rate in a selected series of patients.
For this survey we have the advantage of
starting with a circumscribed geographical
area, namely that ofthe Birmingham Region,
for which all cancer registrations from all
sources are collected centrally. Population
estimates for the specified area were taken
from the Registrar General's Census Popula-
tion Report (Registrar General, 1961). Thus
all factors used in the following computations
refer to the same population.
The series consisted of all registrations
during the years 1950 to 1964 inclusive for a
primary tumour in salivary gland tissue,
and included 372 males and 453 females. The
Fig. shows similar age distributions for eachi
sex. All registrations were included, because
the borderline between the benign and
malignant state is particularly difficult to
determine in salivary gland tumours andMULTIPLE PRIMARY TUMOURS
tumours are relatively rare events, the
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occurring by chance was computed from the
I Poisson distribution.
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TABLE I.-Distribution ofSubsequent
Primary Tumour3s
Site
Breast
Bronchus
Skin
Prostate
Colon
Rectum
Myelomatosis
Oesophagus
Stomach
Uterus
Ovary
Fibrosarcoma
Leukaemia
Bladder
Unknown Primary
Total
Male
4
4
3
1
1
1
1
1
1
Female
6
3
2
2
1
1
1
1
1
1
Total
6
7
6
3
3
2
2
1
1
1
1
1
1
1
1
17 20 37
5- 15- 25- 35- 45- 55- 65- 75- 85+
10-YEAR AGE GROUPS
FIc. Age dlistribution of patients with
salivary-gland tumours (Percentage of
total for each sex).
because serial sections were not available for
each case. Thus, although some ofthe tumours
have been classed as histologically benign,
it is accepted (Willis, 1967) that these
tumours can and often do recur in a malignant
form at a later date. Histological reports for
tumours in this series, therefore, ranged
from mixed salivary type of indeterminate
malignancy to the frankly malignant mixed
salivary, adeno- and anaplastic carcinomas.
Expected incidence rates for tumours at
all sites, and also at more than 50 individual
sites, were computed from Registry morbidity
data for 1960-1962 and census population
figures centred on the year 1961. The result-
ant rates were applied to the series, expressed
as patient-years at risk in terms of sex, age
and years from first primary, to give expected
numbers of tumours at each site and overall.
Observed numbers ofsecond primary tumours
were obtained by scanning the Registry data,
and these tumours are tabulated by sex and
site in Table I. Only those tumours which
occurred after the salivary-gland tumour
have been considered in the following
analyses. With the assumption that such
RESULTS
Table II displays, by site and sex, the
computed number of expected tumours,
together with the number of tumours
observed at these sites. The probabilities
ofthe observed number or more occurring
by chance are given in the final column.
Overall, a highly significant (P<0 001)
excess of tumours was observed. For each
sex the observed number significantly
exceeded expectation (P<0 05 for males
and P<0*01- for females). There were
significant excesses (P<0.05) of tumours
of the breast and bronchus in females,
and of prostate and skin in males. For
males, myelomatosis and fibrosarcoma
also gave significant results but, as these
results were based on single and possibly
random events, too much emphasis should
not be placed on them. For this reason the
fibrosarcoma has. been included in the
"Remainder" group, but as one case of
myelomatosis (P 0.053) was also ob-
served in females, this site has been
included in the main analysis, because the
total effect for the two tumours was
significant (P<0-01). In the "Remainder"
group the observed number of 5 tumours
in males is close to expectation, whereas
FREQUENCY
,nl X
25
20
15
10
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TABLE II. Analysis ofSubsequent Primary Tumours
Number of subsequent
tumours
Sex Expectedl Observe(d
Male
Female
Total
Male
Female
Total
Male
Female
Total
AMale
Female
Total
MIale
Female
Total
Male
Female
Total
Male
Female
Total
9 30
10-75
20 05
0-01
2 )60
2*61
0589
0.99
l 88
0 71
0 71
2 82
0 46
3-28
0 04
0 05
(0(9
4 83
6 65
11 48
17
20
37
6
6
4
2
6
3
:3
4
3
7
1
15
8
1:3
for females there is a small but non-
significant excess of 2 tumours.
DISCUSSION
Breast
Breast was the most frequent second
primary site in females, and the 6 tumours
recorded here were significantly more than
expected. Standing alone, a result at this
level of significance does not provide
unequivocal evidence for the association
but, taken in conjunction with Berg's
observation, it does add support to his
thesis.
Further confirmation, however, comes
from the result of the complementary
analysis carried out on a series of breast-
cancer patients in the Birmingham survey.
Taking breast as the first primary site, a
large body of information was available:
over 20,000 breast tumours had been
registered between 1936 and 1964. Using
the method outlined above, it was com-
puted that 2 7 subsequent tumours might
be expected to occur in salivary glands.
Eight tumours in 7 patients were, in fact,
recorded, the difference between observed
and expected numbers was, again, sig-
nificant (P<0 05) at the same level as
that for the complementary survey.
In addition to the 13 patients included
in these two analyses, 9 other patients
are knowni to have tumours at both sites,
but these, for statistical reasons, could
not be included in the analyses, either
because the first primary occurred before
1950 or the second primary after 1965, or
because the first primary had been
diagnosed while the patient was resident
outside the Birmingham Region. A further
.5 patients, registered for a tumour in
either breast or salivary gland, are known
to have displayed a pathological, though
not malignant, condition at the other site.
Comparative figures for the four surveys
are given in Table III. The number of
patients and patient-years at risk were of
the same order for each survey, although
the mean period of observation ranged
Site
All Sites
Breast
Skin
Prostate
Bronchus
MIyelomatosis
Remainder
Pt
*
**
**
*
*
**
**
*
*
*
**
t* P <0.05
** P<0-01
*** P<0.001
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TABLE III. Comparison Between 4 Surveys
Study
Berg et al. (1968)
Moertel and Elveback (1969)
Dunn et al. (1972)
Present report
No. of cases Breast tumours
with salivary- Women-years -
gland tumours at risk Expected Observed
396
297
349
453
1651-75
3033-0
2443-0
2315-0
0-91
4-01
4.22
2-6
7
4
8
6
1 Based on New York State registrations.
2 Based on Alameda County incidence rates.
t For P valuies see footnote to Table II.
from 4-2 years in Berg's series to 10-2 in
Moertel's. The main discrepancy between
our series and that of Berg lies in the
expected number. Even allowing for fewer
cases and the shorter period ofobservation,
it is doubtful whether such a discrepancy
could be due solely to the small difference
in incidence rates for New York State
and Birmingham (Doll, Payne and Water-
house, 1966) because Moertel, also using
rates for New York State found no
excess. In addition, Moertel showed that
by using rates for three different areas the
expected number varied only between 4 0
and 4a7. He also pointed out that the
application of tumour-registry rates to
hospital-based data, such as that from the
Mayo Clinic and the Memorial Centre, is of
doubtful validity, because of the many
sources of bias in the selection of the
series.
Although Dunn used an appropriate
incidence rate for computation (Alameda
County), the series was drawn from total
registrations for the State of California.
The authors admitted that the methods of
notification might lead to a small deficit in
the observed numbers of second primaries,
but they maintained that the loss could
not be as great as 20 breast cancers, the
number that would be needed to bring
their demonstrated two-fold risk up to
the eight-fold risk in Berg's series. If,
however, only one case had been missed,
the relative risk in Dunn's series (2.1)
would be very close to that found in our
own (2 3).
Ifthe relatively low expected number in
Berg's analysis cannot be attributed to
the choice of incidence rates, it is possible
that his series comprised mainly young
women. Our results (Table IV) showed
that the risk was higher in younger women
compared with the overall effect. The level
of risk was, however, still much less than
eight-fold.
Over the years, Moertel has been
pertinently critical of methodology in the
multiple primary field, and the addition of
our results to this particular sector
confirms his opinion: "Neither player
wins the match and confusion reigns." In
supporting the validity of our own results,
we can only reiterate that the survey was
population-based, with both series and
incidence rates being derived from the
same population, and that the loss to
follow-up was less than 1%.
TABLE IV. Second Primary Tumours in Relation to Age atDiagnosis oftheFirst Primary
Tumour
1st primary site:
2nd primary site:
Age (1st Primary)
< 60 years
60+ years
Total
t For P values see footnote to Table II.
Pt
*
Salivary gland
Breast
Obs.
4
2
Exp.
1-53
1-06
2-59
p
6 *
Breast
Salivary gland
Obs.
7
1
Exp.
1-71
1-01
2-72
Pt
**
8 *
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Skin
Second primary tumours of skin were
in excess in males, but for females the
excess of observed tumours did not reach
the 5%0 significance level. Berg also found
an excess at this site, which he attributed
to radiotherapy given for a non-malignant
skin condition (chronic acne). There was
no evidence among the Birmingham series
for such an association nor for radio-
therapy given as treatment to the salivary
gland tumour.
Prostate
The 3 tumours observed at this site
were significantly in excess ofexpectation.
It is possible that one tumour should
belong to the complementary survey of
prostate to salivary gland, but the
frequency of long-standing pre-malignant
phases at these sites made any arbitrary
decision difficult. All 3 tumours were,
however, symptomatic.
Bronchus
Because lung-cancer rates rose rapidly
over the period, an over-estimation of the
expected number (based on the 1961 rate)
might have been anticipated. However,
from a comparative cohort mortality
analysis for males, based on the Case-
Pearson mortality tables (Case and Pear-
son, 1968) no appreciable difference was
found-2-4 deaths expected compared
with 2-8 cases from morbidity analysis.
This was probably due to the fact that
a large proportion of the person-years at
risk do fall around 1961.
Single tumours
Expected numbers for myelomatosis
and fibrosarcoma show these conditions
to be relatively rare, so that single
tumours occurring at these sites give
"significant" results, but the possibility
that single cases are random events must
not be overlooked. The occurrence of one
case of myelomatosis in each sex suggests
that this site merits further observation.
Etiology
Berg reported that the association
between breast and salivary gland was
more evident in patients with muco-
epidermoid tumours in the salivary tissue.
It was not possible to assess a similar
effect in retrospect in the Birmingham
series but, of the 13 patients with both
breast and salivary gland tumours, 7
developed breast tumours ofthe intraduct
type, 4 of whom suffered concurrent
mastitis, in addition to Paget's disease of
the nipple in one case, and a history of
cysts of the breast in another. Whether
this picture of low-grade or early malig-
nancy is of significance in this context, or
whether it merely defines a group with a
good prognosis (and hence a longer
period at risk for a second primary)
cannot be determined from the present
data.
With breast, skin and prostate emerging
as associated sites in this analysis, the
possibility ofhormone involvement should
not be overlooked. Whether abnormal
hormone stimulation is the initiating
factor for tumours at these sites is stillnot
clear, but it was shown (Bulbrook et al.,
1962) that abnormal levels of urinary
steroids could be detected before the
diagnosis of breast tumours, and that
endocrine abnormalities were similar for
both breast and prostate (Stern et al.,
1964).
Increased sebum secretion in the skin of
breast cancer patients has been reported
(Burton, Cunliffe and Shuster, 1970;
Wang et al., 1972) the latter authors
suggesting a possible hormonal link and,
certainly, fluctuating hormonal levels
appear to affect the activity ofskin during
adolescence, pregnancy and the menstrual
cycle. It may be, then, that the excess of
skin tumours, attributed by Berg to
radiotherapy, was instead due to the
condition for which they were treated,
namely chronic acne, which suggests a
long-standing hormonal imbalance. Pre-
liminary results from the Birmingham
survey indicate a possible positive associa-
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tionl between breast and skin cancer, but
the results await more detailed appraisal.
For tumours of the lung, too, the
presence of abnormally low levels of
androsterone in relation to both aetio-
cholanolone and 17-hydroxycorticosteroids
which were not affected by the removal of
the tumours have been reported (Rao,
1972). It is interesting to note here, also,
that an excess of second primary tumours
subsequent to salivary gland tumours,
found in black males, was due mainly to
tumours in lung and prostate (Newell,
Krementz and Roberts, 1974).
Evidence for hormonal involvement in
normal or malignant salivary-gland tissue
is not so clear, although a possible
endocrine link between oncocytoma of the
salivary gland and a similar type of
nodular hyperplasia found in other organs
with either hormonal function or depen-
dence may exist (Blanck, Eneroth and
Jakobsson, 1970). Also, breast, skin and
salivary gland have been linked with
respect to clear-cell hidradenoma, and it
has been postulated that these glandular
tissues contain multipotential reserve cells
which give rise to comparable tumours at
these sites (Finek, Schwinn and Keasby,
1968).
Evidence that steroid hormones can
pass through the salivary tissue comes
from tests which showed that oestrogen
levels in saliva reflected changing plasma
levels during pregnancy (Heap and Broad,
1974). This does not, however, provide
conclusive evidence that the gland activity
metabolizes steroids.
Animal investigations (Glucksmann and
Cherry, 1966) showed that DMBA-induced
tumours ofthe salivary glands in rats were
dependent on testosterone levels, and that
incidence was sex related. In the human
situation, incidence varies little with sex
(males-l 4/105/year; females-I 17/105/
year) but these results do suggest that in
some situations steroid hormones can play
a part in the development of tumours of
the salivary gland.
In mice, a lethal factor, which is
produced or stored in the submandibular
glands of mature males, is also testo-
sterone-dependent (Hoshino and Lin,
1969). An epithelial-epidermoid growth
factor in submandibular glands of male
mice has also been demonstrated, which
stimulates the growth of epidermal cells
and also mouse mammary tumour cells.
Production of this factor is also influenced
by testosterone (Turkington, 1969).
An abnormal hormonal status could,
then, link and possibly account for the
associations found in this survey. The
generally low level of significance of the
relationships suggests that the risk lies
within a sub-group ofthe series, andtaking
into account the fragmentary evidence,
outlined above for the individual sites, the
possibility that the associations represent
the effect of a common etiological factor-
abnormal androgen metabolism being
the prime suspect warrants further in-
vestigation.
The Survey of Multiple Primary Malig-
nant Tumours is supported by the Cancer
Research Campaign.
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